These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16753284)

  • 21. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective chart review of the clinical effects of atypical antipsychotic drugs on glycemic control in institutionalized patients with schizophrenia and comorbid diabetes mellitus.
    Krosnick A; Wilson MG
    Clin Ther; 2005 Mar; 27(3):320-6. PubMed ID: 15878385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics.
    Chen DC; Zhou MA; Zhou DH; Xiu MH; Wu GY; Kosten TR; Zhang XY
    Psychiatry Res; 2011 Apr; 186(2-3):451-3. PubMed ID: 20797801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
    Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
    Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National trends in metabolic risk of psychiatric inpatients in the United States during the atypical antipsychotic era.
    Gao YN; Olfson M
    Schizophr Res; 2022 Oct; 248():320-328. PubMed ID: 36155305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
    Bou Khalil R
    Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs.
    Lamberti JS; Crilly JF; Maharaj K; Olson D; Wiener K; Dvorin S; Costea GO; Bushey MP; Dietz MB
    J Clin Psychiatry; 2004 May; 65(5):702-6. PubMed ID: 15163259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes and schizophrenia 2005: are we any closer to understanding the link?
    Holt RI; Bushe C; Citrome L
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):56-65. PubMed ID: 16280338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors in second-generation antipsychotic switching patterns in a national sample of older veterans with schizophrenia.
    Dassori AM; Copeland LA; Zeber JE; Miller AL
    Psychiatr Serv; 2011 Jan; 62(1):47-53. PubMed ID: 21209299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of psychiatric condition and medication on the prevalence of diabetes in a psychiatric out-patient clinic: an audit.
    Coulson M; Agius M; Zaman R
    Psychiatr Danub; 2012 Sep; 24 Suppl 1():S128-9. PubMed ID: 22945205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
    Miller DD; McEvoy JP; Davis SM; Caroff SN; Saltz BL; Chakos MH; Swartz MS; Keefe RS; Rosenheck RA; Stroup TS; Lieberman JA
    Schizophr Res; 2005 Dec; 80(1):33-43. PubMed ID: 16171976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Schizophrenia and diabetes mellitus: not an improbable combination].
    Cohen D; Gispen-de Wied CC
    Ned Tijdschr Geneeskd; 2003 May; 147(21):993-6. PubMed ID: 12811967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes, pre-diabetes and associated risks on Minnesota code-indicated major electrocardiogram abnormality among Chinese: a cross-sectional diabetic study in Fujian province, southeast China.
    Lin L; Chen G; Zou X; Zhao J; Zhu F; Tu M; Xu S; Lin W; Yang S; Zhang Y; Lin M; Chen N; Huang H; Liang J; Li L; Yao J
    Obes Rev; 2009 Jul; 10(4):420-30. PubMed ID: 19460110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.
    McIntyre RS; Jerrell JM
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):929-35. PubMed ID: 18838645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.